Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Licenses Resolver to Aventis

NEW YORK, Dec. 11 - Rosetta Biosoftware said on Tuesday that   it has licensed its Rosetta Resolver gene-expression data-analysis system to Aventis Pharmaceuticals.


Financial or research specifics of the agreement were not revealed.


"The Rosetta Resolver system's ability to be networked into a multi-server global solution for our distributed enterprise was important to us," Christoph Brockel, head of Aventis Pharma's informatics group, said in a statement.


Rosetta Biosoftware is based in Kirkland, Wash., and Aventis Pharmaceuticals, of Cambridge, Mass., is the US business of German life sciences group Aventis Pharma.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.